Merck Builds Risk Management Into Drug Development; Hires FDA’s Honi
Executive Summary
Merck is building risk management into its product development strategy with the hiring of FDA Office of Drug Safety Director Peter Honig, MD
You may also be interested in...
IoM Drug Safety Study May Buy Time For FDA; Report Will Play In PDUFA IV
FDA's decision to proceed with an Institute of Medicine review of drug safety regulation could trigger a full-fledged debate over the possibility of creating a separate post-marketing regulatory agency in the U.S
IoM Drug Safety Study May Buy Time For FDA; Report Will Play In PDUFA IV
FDA's decision to proceed with an Institute of Medicine review of drug safety regulation could trigger a full-fledged debate over the possibility of creating a separate post-marketing regulatory agency in the U.S
FDA Handling Of Antidepressant Inquiry “Troubles” Senate Investigators
The Senate Finance Committee is asking for contact information for former employees of FDA's Office of Drug Safety in its continuing investigation into the agency's handling of information on a possible link between antidepressants and suicide